Alterity Therapeutics Ltd. Sponsored ADR Forecast, price target & analysts
Alterity Therapeutics Ltd. Sponsored ADR Target price 2025 - Analyst rating & recommendation
Alterity Therapeutics Ltd. Sponsored ADR Price Target
| Target Price | $12.00 |
| Price | $4.25 |
| Potential |
182.35%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Alterity Therapeutics Ltd. Sponsored ADR price target 2026.
The average Alterity Therapeutics Ltd. Sponsored ADR target price is $12.00.
This is
182.35%
register free of charge
|
|
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Alterity Therapeutics Ltd. Sponsored ADR stock has an average upside potential 2026 of
182.35%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2032
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.29 | 2.70 |
| 61.11% | 832.24% | |
| EBITDA Margin | -3,203.45% | -501.23% |
| 54.49% | 84.35% | |
| Net Margin | -2,765.52% | 0.00% |
| 60.59% | 100.00% |
3 Analysts have issued a sales forecast Alterity Therapeutics Ltd. Sponsored ADR 2026 . The average Alterity Therapeutics Ltd. Sponsored ADR sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Alterity Therapeutics Ltd. Sponsored ADR EBITDA forecast 2026. The average Alterity Therapeutics Ltd. Sponsored ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.00 | 0.00 |
| EV/Sales | 18.50 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
